Onychomycosis (Tinea Unguium) Drug Market Report

Onychomycosis (Tinea Unguium) Drug Market - Global Professional Analysis and Forecast to 2026

  • POSTDATE：Apr 23, 2020
  • PAGES：195
  • REPORT CODE：GMM531213
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The worldwide Onychomycosis (Tinea Unguium) Drug market was valued at 0.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.2% during the forecast period.

    This report presents the market size and development trends by detailing the Onychomycosis (Tinea Unguium) Drug market revenue, market share and growth rate from 2015-2026, and it gives a thorough analysis by various product types, applications, regions, and main participants. The market conditions (2015-2019), corporate competition pattern, corporate SWOT analysis are elaborated, and other qualitative analyses like market dynamics, market penetration, market business environment analyses, the regional regulatory scenario in the Onychomycosis (Tinea Unguium) Drug market will be shown in this report. In short, this report will comprehensively reveal the characteristics of Onychomycosis (Tinea Unguium) Drug industry and will help you to build a panoramic view of the industrial development.

    Onychomycosis (Tinea Unguium) Drug Market, By Type:

    • Oral medication

    • External medicine

    Onychomycosis (Tinea Unguium) Drug Market, By Application:

    • The Middle-aged

    • Children

    • The Aged

    Some of the leading players are as follows:

    • Moberg

    • Valeant Pharma

    • Pfizer

    • Hubei Hengan

    • Novartis

    • Torrent Pharma

    • Perrigo

    • TARO

    • Yangtze River

    • Galderma

    • Zhejiang Deyer

    • Qilu Pharmaceutical

    • J&J

    • Xiuzheng Pharmaceutical

    • Chengdu Brilliant

    Geographically, Major regions are analyzed in details are as follows:

    • North America

    • Europe

    • Asia Pacific

    • Latin America

    • Middle East & Africa

  • Table of Contents

    1 Methodology and Scope

    • 1.1 Market Segmentation & Scope

      • 1.1.1 Technology Type

      • 1.1.2 Product

      • 1.1.3 Application

      • 1.1.4 Regional scope

      • 1.1.5 Estimates and forecast timeline

    • 1.2 Research Methodology

    • 1.3 Information Procurement

      • 1.3.1 Purchased database

      • 1.3.2 Internal database

      • 1.3.3 Secondary sources

      • 1.3.4 Primary research

      • 1.3.5 Details of primary research

    • 1.4 Information or Data Analysis

      • 1.4.1 Data analysis models

    • 1.5 Market Formulation & Validation

    • 1.6 Model Details

      • 1.6.1 Commodity flow analysis

      • 1.6.2 Volume price analysis

    • 1.7 List of Secondary Sources

    • 1.8 List of Abbreviations

    2 Executive Summary

    • 2.1 Market Outlook

    • 2.2 Segment Outlook

    3 Market Variables, Trends, & Scope

    • 3.1 Market Lineage Outlook

      • 3.1.1 Parent market outlook

      • 3.1.2 Ancillary market outlook

    • 3.2 Market Segmentation

      • 3.2.1 Analysis

    • 3.3 Market Dynamics

      • 3.3.1 Market driver analysis

      • 3.3.2 Market restraint analysis

      • 3.3.3 Industry opportunities

    • 3.4 Penetration & Growth Prospect Mapping

      • 3.4.1 Penetration & growth prospect mapping analysis

    • 3.5 Business Environment Analysis Tools

      • 3.5.1 Porter's five forces analysis

      • 3.5.2 PESTLE analysis

      • 3.5.3 Major deals & strategic alliances analysis

    4 Onychomycosis (Tinea Unguium) Drug Market: Technology Type Analysis

    • 4.1 Onychomycosis (Tinea Unguium) Drug Technology Type Market Share Analysis, 2018 & 2026

    • 4.2 Onychomycosis (Tinea Unguium) Drug Technology Type Market: Segment Dashboard

    • 4.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Technology Type Segment

      • 4.3.1 Oral medication

      • 4.3.2 External medicine

    5 Onychomycosis (Tinea Unguium) Drug Market: Product Analysis

    • 5.1 Onychomycosis (Tinea Unguium) Drug Product Market Share Analysis, 2018 & 2026

    • 5.2 Onychomycosis (Tinea Unguium) Drug Product Market: Segment Dashboard

    • 5.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Product Segment

    6 Onychomycosis (Tinea Unguium) Drug Market: Application Analysis

    • 6.1 Onychomycosis (Tinea Unguium) Drug Application Market Share Analysis, 2018 & 2026

    • 6.2 Onychomycosis (Tinea Unguium) Drug Application Market: Segment Dashboard

    • 6.3 Market Size & Forecasts and Trend Analyses, 2015 to 2026 for the Application Segment

      • 6.3.1 The Middle-aged

      • 6.3.2 Children

      • 6.3.3 The Aged

    7 Onychomycosis (Tinea Unguium) Drug Market: Regional Analysis

    • 7.1 Onychomycosis (Tinea Unguium) Drug Regional Market Share Analysis, 2018 & 2026

    • 7.2 Onychomycosis (Tinea Unguium) Drug Regional Market: Segment Dashboard

    • 7.3 Regional Market Snapshot (Market Size, CAGR, Top Countries)

    • 7.4 List of Players at Regional Level

      • 7.4.1 North America

      • 7.4.2 Europe

      • 7.4.3 Asia Pacific

    • 7.5 SWOT Analysis, by Factor (Political & Legal, Economic and Technological)

      • 7.5.1 North America

      • 7.5.2 Europe

      • 7.5.3 Asia Pacific

      • 7.5.4 Latin America

      • 7.5.5 MEA

    • 7.6 Market Size & Forecasts, and Trend Analysis, 2015 to 2026

      • 7.6.1 North America

      • 7.6.2 Europe

      • 7.6.3 Asia Pacific

      • 7.6.4 Latin America

      • 7.6.5 Middle East & Africa

    8 Competitive Analysis

    • 8.1 Recent Developments & Impact Analysis, by Key Market Participants

    • 8.2 Strategic Framework/Competition Categorization (Key innovators, Market leaders, Emerging players)

    • 8.3 Vendor Landscape

      • 8.3.1 Company market position analysis (Geographic presence, service portfolio, strategic initiatives)

    9 Company Profiles

    • 9.1 Moberg

      • 9.1.1 Moberg Company Profile and Recent Development

      • 9.1.2 Market Performance

      • 9.1.3 Product and Service Introduction

    • 9.2 Valeant Pharma

      • 9.2.1 Valeant Pharma Company Profile and Recent Development

      • 9.2.2 Market Performance

      • 9.2.3 Product and Service Introduction

    • 9.3 Pfizer

      • 9.3.1 Pfizer Company Profile and Recent Development

      • 9.3.2 Market Performance

      • 9.3.3 Product and Service Introduction

    • 9.4 Hubei Hengan

      • 9.4.1 Hubei Hengan Company Profile and Recent Development

      • 9.4.2 Market Performance

      • 9.4.3 Product and Service Introduction

    • 9.5 Novartis

      • 9.5.1 Novartis Company Profile and Recent Development

      • 9.5.2 Market Performance

      • 9.5.3 Product and Service Introduction

    • 9.6 Torrent Pharma

      • 9.6.1 Torrent Pharma Company Profile and Recent Development

      • 9.6.2 Market Performance

      • 9.6.3 Product and Service Introduction

    • 9.7 Perrigo

      • 9.7.1 Perrigo Company Profile and Recent Development

      • 9.7.2 Market Performance

      • 9.7.3 Product and Service Introduction

    • 9.8 TARO

      • 9.8.1 TARO Company Profile and Recent Development

      • 9.8.2 Market Performance

      • 9.8.3 Product and Service Introduction

    • 9.9 Yangtze River

      • 9.9.1 Yangtze River Company Profile and Recent Development

      • 9.9.2 Market Performance

      • 9.9.3 Product and Service Introduction

    • 9.10 Galderma

      • 9.10.1 Galderma Company Profile and Recent Development

      • 9.10.2 Market Performance

      • 9.10.3 Product and Service Introduction

    • 9.11 Zhejiang Deyer

      • 9.11.1 Zhejiang Deyer Company Profile and Recent Development

      • 9.11.2 Market Performance

      • 9.11.3 Product and Service Introduction

    • 9.12 Qilu Pharmaceutical

      • 9.12.1 Qilu Pharmaceutical Company Profile and Recent Development

      • 9.12.2 Market Performance

      • 9.12.3 Product and Service Introduction

    • 9.13 J&J

      • 9.13.1 J&J Company Profile and Recent Development

      • 9.13.2 Market Performance

      • 9.13.3 Product and Service Introduction

    • 9.14 Xiuzheng Pharmaceutical

      • 9.14.1 Xiuzheng Pharmaceutical Company Profile and Recent Development

      • 9.14.2 Market Performance

      • 9.14.3 Product and Service Introduction

    • 9.15 Chengdu Brilliant

      • 9.15.1 Chengdu Brilliant Company Profile and Recent Development

      • 9.15.2 Market Performance

      • 9.15.3 Product and Service Introduction

     

    The List of Tables and Figures (Totals 86 Figures and 151 Tables)

    • Figure Market Size and Growth Rate of Oral medication

    • Figure Market Size and Growth Rate of External medicine

    • Figure Market Size and Growth Rate of The Middle-aged

    • Figure Market Size and Growth Rate of Children

    • Figure Market Size and Growth Rate of The Aged

    • Table List of players in North America

    • Table List of players in Europe

    • Table List of players in Asia Pacific

    • Table SWOT analysis

    • Table North America Onychomycosis (Tinea Unguium) Drug market, by country, 2015 - 2026 (USD Million)

    • Table North America Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table North America Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table North America Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.S. Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table U.S. Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table U.S. Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Canada Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Canada Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Canada Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Europe Onychomycosis (Tinea Unguium) Drug market, by country, 2015 - 2026 (USD Million)

    • Table Europe Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Europe Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Europe Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table U.K. Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table U.K. Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table U.K. Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Germany Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Germany Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Germany Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table France Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table France Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table France Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Italy Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Italy Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Italy Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Spain Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Spain Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Spain Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Asia Pacific Onychomycosis (Tinea Unguium) Drug market, by country, 2015 - 2026 (USD Million)

    • Table Asia Pacific Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Asia Pacific Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Asia Pacific Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table China Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table China Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table China Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Japan Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Japan Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Japan Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table India Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table India Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table India Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Latin America Onychomycosis (Tinea Unguium) Drug market, by country, 2015 - 2026 (USD Million)

    • Table Latin America Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Latin America Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Latin America Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Brazil Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Brazil Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Brazil Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Mexico Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Mexico Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Mexico Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Argentina Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Argentina Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Argentina Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table MEA Onychomycosis (Tinea Unguium) Drug market, by country, 2015 - 2026 (USD Million)

    • Table MEA Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table MEA Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table MEA Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table South Africa Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table South Africa Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table South Africa Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Regulatory scenario

    • Table Nigeria Onychomycosis (Tinea Unguium) Drug market, by type, 2015 - 2026 (USD Million)

    • Table Nigeria Onychomycosis (Tinea Unguium) Drug market, by product, 2015 - 2026 (USD Million)

    • Table Nigeria Onychomycosis (Tinea Unguium) Drug market, by application, 2015 - 2026 (USD Million)

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Recent Developments & Impact Analysis, by Key Market Participants

    • Table Company market position analysis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Moberg

    • Figure Sales and Growth Rate Analysis of Moberg

    • Figure Revenue and Market Share Analysis of Moberg

    • Table Product and Service Introduction of Moberg

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valeant Pharma

    • Figure Sales and Growth Rate Analysis of Valeant Pharma

    • Figure Revenue and Market Share Analysis of Valeant Pharma

    • Table Product and Service Introduction of Valeant Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer

    • Figure Sales and Growth Rate Analysis of Pfizer

    • Figure Revenue and Market Share Analysis of Pfizer

    • Table Product and Service Introduction of Pfizer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hubei Hengan

    • Figure Sales and Growth Rate Analysis of Hubei Hengan

    • Figure Revenue and Market Share Analysis of Hubei Hengan

    • Table Product and Service Introduction of Hubei Hengan

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis

    • Figure Sales and Growth Rate Analysis of Novartis

    • Figure Revenue and Market Share Analysis of Novartis

    • Table Product and Service Introduction of Novartis

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Torrent Pharma

    • Figure Sales and Growth Rate Analysis of Torrent Pharma

    • Figure Revenue and Market Share Analysis of Torrent Pharma

    • Table Product and Service Introduction of Torrent Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Perrigo

    • Figure Sales and Growth Rate Analysis of Perrigo

    • Figure Revenue and Market Share Analysis of Perrigo

    • Table Product and Service Introduction of Perrigo

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of TARO

    • Figure Sales and Growth Rate Analysis of TARO

    • Figure Revenue and Market Share Analysis of TARO

    • Table Product and Service Introduction of TARO

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Yangtze River

    • Figure Sales and Growth Rate Analysis of Yangtze River

    • Figure Revenue and Market Share Analysis of Yangtze River

    • Table Product and Service Introduction of Yangtze River

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Galderma

    • Figure Sales and Growth Rate Analysis of Galderma

    • Figure Revenue and Market Share Analysis of Galderma

    • Table Product and Service Introduction of Galderma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zhejiang Deyer

    • Figure Sales and Growth Rate Analysis of Zhejiang Deyer

    • Figure Revenue and Market Share Analysis of Zhejiang Deyer

    • Table Product and Service Introduction of Zhejiang Deyer

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Qilu Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Qilu Pharmaceutical

    • Figure Revenue and Market Share Analysis of Qilu Pharmaceutical

    • Table Product and Service Introduction of Qilu Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of J&J

    • Figure Sales and Growth Rate Analysis of J&J

    • Figure Revenue and Market Share Analysis of J&J

    • Table Product and Service Introduction of J&J

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Xiuzheng Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Xiuzheng Pharmaceutical

    • Figure Revenue and Market Share Analysis of Xiuzheng Pharmaceutical

    • Table Product and Service Introduction of Xiuzheng Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chengdu Brilliant

    • Figure Sales and Growth Rate Analysis of Chengdu Brilliant

    • Figure Revenue and Market Share Analysis of Chengdu Brilliant

    • Table Product and Service Introduction of Chengdu Brilliant

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US